BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 352667)

  • 1. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Aug; 16(2):97-114. PubMed ID: 352667
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical and biological studies on indomethacin, sulindac and their analogs.
    Shen TY; Winter CA
    Adv Drug Res; 1977; 12():90-245. PubMed ID: 343530
    [No Abstract]   [Full Text] [Related]  

  • 3. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.
    Sorkin EM; Brogden RN
    Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic polyarthritis with Sulindac].
    Vetter G; Picha B
    MMW Munch Med Wochenschr; 1977 Oct; 119(42):1369-70. PubMed ID: 412071
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulindac. Trials of a new anti-inflammatory drug.
    Huskisson EC; Scott J
    Ann Rheum Dis; 1978 Feb; 37(1):89-92. PubMed ID: 343728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac.
    Lancet; 1977 Feb; 1(8009):462-3. PubMed ID: 65569
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of sulindac and aspirin in rheumatoid arthritis.
    Reynolds PM; Rhymer AR; MacLeod MM; Buchanan WW
    Curr Med Res Opin; 1977; 4(7):485-91. PubMed ID: 321183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Jun; 15(6):429-50. PubMed ID: 350558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)].
    Fasching U; Eberl R
    Wien Klin Wochenschr Suppl; 1976; 59():1-10. PubMed ID: 136815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cooperative clinical study of Sulindac in arthrosis (hip joint and knee) in general medicine].
    Delcambre B
    Lille Med; 1977 Apr; 22(4 Suppl 1):266-8. PubMed ID: 327175
    [No Abstract]   [Full Text] [Related]  

  • 11. [MK-231 (Sulindac) in the treatment of rheumatoid arthritis (author's transl)].
    Bachmann F; Hartl W
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1772-5. PubMed ID: 336322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Open clinical therapeutic trial using Clinoril in gonarthroses].
    Truhlár P; Machácek P
    Fysiatr Revmatol Vestn; 1978 Jun; 56(3):146-8. PubMed ID: 352880
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoprofen. A survey of current publications.
    Fossgreen J
    Scand J Rheumatol Suppl; 1976; 1976(0):7-32. PubMed ID: 136040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulindac in arthrosis and rheumatoid arthritis].
    Baumgartner H
    Verh Dtsch Ges Rheumatol; 1978; 5():264-6. PubMed ID: 706677
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis.
    Fumagalli M; Cunietti E; Vaiani G; Monti M; Ferrari F; Gandini R
    Clin Ther; 1986; 8(3):292-300. PubMed ID: 3521858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night medication in rheumatoid arthritis. III. the use of sulindac.
    Sharma BK; Haslock I
    Curr Med Res Opin; 1978; 5(6):472-5. PubMed ID: 350499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Dec; 18(6):417-38. PubMed ID: 391529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.